← Back to Torrent Pharmaceuticals Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
TORNTPHARMPharmaceuticals

Torrent Pharmaceuticals Ltd — Profit & Loss Statement

₹4220.20
-0.74%

Torrent Pharmaceuticals Ltd Profit & Loss Statement (Annual)

Metric2025202420232022
Total Unusual Items Excluding Goodwill-6.14 Cr93.38 Cr36.57 Cr-474.79 Cr
Net Income From Continuing Operation Net Minority Interest1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Reconciled Depreciation794.93 Cr795.30 Cr702.03 Cr661.93 Cr
Reconciled Cost Of Revenue2.88K Cr2.79K Cr2.83K Cr2.54K Cr
EBITDA3.72K Cr3.50K Cr2.88K Cr2.14K Cr
EBIT2.92K Cr2.70K Cr2.18K Cr1.48K Cr
Net Interest Income-232.12 Cr-342.08 Cr-318.66 Cr-247.91 Cr
Interest Expense251.38 Cr352.63 Cr332.24 Cr252.93 Cr
Interest Income20.19 Cr11.48 Cr14.78 Cr7.15 Cr
Normalized Income1.92K Cr1.59K Cr1.22K Cr1.08K Cr
Net Income From Continuing And Discontinued Operation1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Total Expenses8.39K Cr7.99K Cr7.32K Cr6.65K Cr
Diluted Average Shares33.84 Cr33.84 Cr33.84 Cr33.84 Cr
Basic Average Shares33.84 Cr33.84 Cr33.84 Cr33.84 Cr
Diluted EPS56.4748.9436.7922.96
Basic EPS56.4748.9436.7922.96
Diluted NI Availto Com Stockholders1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Net Income Common Stockholders1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Minority Interests0.000.000.000.00
Net Income Including Noncontrolling Interests1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Net Income Continuous Operations1.91K Cr1.66K Cr1.25K Cr777.18 Cr
Tax Provision761.56 Cr695.73 Cr601.93 Cr448.73 Cr
Pretax Income2.67K Cr2.35K Cr1.85K Cr1.23K Cr
Other Non Operating Income Expenses1.62 Cr32.37 Cr7.31 Cr9.73 Cr
Special Income Charges-22.87 Cr75.39 Cr17.06 Cr-484.93 Cr
Other Special Charges22.87 Cr-88.36 Cr-21.62 Cr45.68 Cr
Impairment Of Capital Assets0.0012.97 Cr4.56 Cr439.25 Cr
Net Non Operating Interest Income Expense-232.12 Cr-342.08 Cr-318.66 Cr-247.91 Cr
Total Other Finance Cost0.93 Cr0.93 Cr1.20 Cr2.13 Cr
Interest Expense Non Operating251.38 Cr352.63 Cr332.24 Cr252.93 Cr
Interest Income Non Operating20.19 Cr11.48 Cr14.78 Cr7.15 Cr
Operating Income2.93K Cr2.57K Cr2.14K Cr1.77K Cr
Operating Expense5.51K Cr5.20K Cr4.50K Cr4.11K Cr
Other Operating Expenses568.92 Cr563.02 Cr513.31 Cr444.92 Cr
Depreciation And Amortization In Income Statement794.93 Cr795.30 Cr702.03 Cr661.93 Cr
Amortization542.71 Cr542.92 Cr476.56 Cr415.70 Cr
Depreciation Income Statement252.22 Cr252.38 Cr225.47 Cr246.23 Cr
Research And Development30.42 Cr24.73 Cr31.27 Cr38.65 Cr
Selling General And Administration2.00K Cr1.90K Cr1.64K Cr1.44K Cr
Selling And Marketing Expense1.26K Cr1.13K Cr1.03K Cr884.91 Cr
General And Administrative Expense738.22 Cr772.28 Cr613.76 Cr554.88 Cr
Gross Profit8.43K Cr7.77K Cr6.64K Cr5.88K Cr
Cost Of Revenue2.88K Cr2.79K Cr2.83K Cr2.54K Cr
Total Revenue11.32K Cr10.56K Cr9.46K Cr8.42K Cr
Operating Revenue11.32K Cr10.56K Cr9.46K Cr8.42K Cr
Tax Effect Of Unusual Items-1.75 Cr27.62 Cr11.92 Cr-173.77 Cr
Tax Rate For Calcs0.280.300.330.37
Normalized EBITDA3.73K Cr3.41K Cr2.84K Cr2.62K Cr
Total Unusual Items-6.14 Cr93.38 Cr36.57 Cr-474.79 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Torrent Pharmaceuticals Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.